NGM-120

N/A

Report date: 2026/04/03 20:03:44
First In Class

Base Information

Drug NameNGM-120
Drug Alias NameNGM-120
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionGrowth/differentiation factor 15 inhibitors
TargetsGrowth/differentiation factor 15
Therapy Area/IndicationsAnorexiaCachexiaHyperemesis Gravidarum +[14
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwanAustralia +[6
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNGM Biopharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsAnorexiaCachexiaHyperemesis Gravidarum +[14
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A